Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Brain wave timing could unlock better stroke recovery

NCT ID NCT03288220

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 01, 2026 · Updated 4 times

Summary

This study aims to understand how the brain responds to magnetic stimulation when it is timed with natural brain waves. Researchers will test healthy adults and people who had a stroke at least 6 months ago. The goal is to find ways to make brain stimulation more effective for improving arm and hand movement.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 114 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2018

Expected to finish

Mar 2029

An estimate. End dates often move.

Lead sponsor

A government research agency

The lead sponsor is the US National Institutes of Health.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Experiment 1: Up to 24 older healthy volunteers (ages 50 and older). Experiment 2 (added in October 2023): Up to 31 young healthy adults (18-49) and 31 older healthy adults (50 and older). Experiment 3: Up to 28 stroke patients (age 18 and older). Total: up to 114 participants.

Ages

18 to 120 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

* INCLUSION CRITERIA: * Healthy younger adults: * Ages 18 years to less than 50 years. (18 to 49) * Willingness/ability to provide informed consent. * Ability to induce a motor evoked potential in the muscle target of the upper extremity, as evaluated during the TMS Screening. * Healthy older adults: * Age 50 and over * Willingness/ability to provide informed consent. * Ability to induce a motor evoked potential in the muscle target of the upper extremity, as evaluated during the TMS Screening. * Stroke patients: * Age 18 and over. * Unilateral or bilateral upper limb paresis with the ability to voluntarily contract a finger, hand, wrist, or elbow muscle in the affected arm(s). * Stroke onset \> 6 months prior to participation. * Intact M1 sufficient to induce motor evoked potentials in the affected upper extremity following ipsilesional TMS, as evaluated during the TMS Screening. * Willingness/ability to provide informed consent. * If the investigator feels the individual s capacity to provide informed consent is questionable, the NIH Human Subjects Protection Unit (HSPU) will be requested to determine the individual s ability to consent. EXCLUSION CRITERIA: * Healthy younger and older adults: * Presence of severe neurological or medical disorder (e.g., Parkinson s disease or multiple sclerosis). * History of seizures. * Chronic use of antipsychotic drugs (e.g., chlorpromazine or clozapine), tri-cyclic or other anti-depressants, benzodiazepines, or prescription stimulants. * TMS contraindications, such as: * Pacemaker, implanted pump, stimulator, cochlear implant, or metal objects inside the eye or skull. * Diagnosed severe hearing loss. * Current pregnancy. * Staff from our section. * Stroke patients: * Presence of severe neurological or medical disorder, other than stroke (e.g., Parkinson s disease or multiple sclerosis). * History of brainstem stroke. * History of seizures. * Chronic use of antipsychotic drugs (e.g., chlorpromazine or clozapine), benzodiazepines, or prescription stimulants. * TMS contraindications, such as: * Pacemaker, implanted pump, stimulator, cochlear implant, or metal objects inside the eye or skull. ---Diagnosed severe hearing loss. * Current pregnancy. * Staff from our section.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Aging are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • National Institutes of Health Clinical Center

    RECRUITING

    Bethesda, Maryland, 20892, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.